2023-11-21 18:00:00
DECRYPTION – The work of a French researcher exploring a new therapeutic target received the Marcel Dassault Prize for innovation in psychiatry.
Heal the depression by simply taking a medication, and spare patients the profound repercussions of the disease on their mental life, their cognitive abilities and their social life? A dream that we can hardly imagine becoming a reality, as this psychiatric pathology is so complex and multifactorial. But there is an urgent need to improve care: 30% of people suffering from major depression do not respond to available treatments. However, the disease is anything but rare: more than 2 million people suffer from it in France, and it is on track to become, according to the World Health Organization, the leading cause of disability by 2030.
What if the answer was hidden in the very heart of our neurons? It is the path that chose to follow a team of French and Canadian researchers. They have developed a new compound which this Tuesday earned Jocelyne Caboche, research director at the CNRS, the Marcel Dassault* 2023 prize for innovation in psychiatry…
This article is reserved for subscribers. You have 83% left to discover.
Black Friday
-70% on digital subscription
Already subscribed? Log in
1700590156
#molecule #opens #perspectives #severe #depression
